Bananas are currently being considered by Ithaca, NY researchers as potential oral vaccine against HBV (Hepatitis B Virus). HBV affects over 2 million people worldwide. The Roswell Park Cancer Institute (RPCI) estimated in 1996 that approximately 20,000 to 25,000 Americans are infected every year.
MoreArdena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life
MoreAbzena, the leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs)
MoreSingapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences,
MoreLos Angeles, CA, USA, ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and
MoreSweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration
MoreBarcelona, Spain, April 20, 2022 – Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it
MoreOSAKA, Japan and TOKYO, Japan. Shionogi & Co., Ltd. and NEC Corporation, today announced the execution of a strategic research
MoreParis, will open in May (18-19) with connectivity, sustainability and user experience identified as the key trends in 2022 influencing innovation
MoreBARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University
MoreCambridge, UK, CellCentric, aclinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, today announces the appointments
More